SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: December 5, 2007
(Date of earliest event reported)
VASOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-18105 11-2871434
-------- ------- ----------
(State or other (Commission File (IRS Employer
jurisdiction of Number) Identification No.)
incorporation)
180 Linden Avenue, Westbury, New York 11590
----------------------------------------------------------------
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code (516) 997-4600
--------------
-------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4c under the Exchange
Act (17 CFR 240.13e-4c)
Item 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS; COMPENSATORY ARRANGEMENTS OF
CERTAIN OFFICERS
(d) On December 5, 2007, the Board of Directors appointed Joseph A.
Giacalone as a director. Mr. Giacalone will also be Chairman of the
Audit Committee.
Joseph A. Giacalone, a certified public accountant, is Director of
Finance and Accounting of Griffon Corporation since December 2007. He
was Director of Finance and Accounting of P & F Industries, Inc. from
August 2004 to October 2007. He was employed by Vasomedical, Inc. from
February 1993 through August 2003. He served as Chief Financial
Officer of Vasomedical, Inc. from January 2000 to August 2003. From
1983 to 1993, Mr. Giacalone was employed by the international
accounting firm of Grant Thornton LLP.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VASOMEDICAL, INC.
By: /s/ John C. K.Hui
------------------------------
John C. K. Hui
President and Chief Executive Officer
Dated: December 11, 2007